The Technology License Agreement for Antigenics Inc. and Aronex Pharmaceuticals was made available today by online legal document provider RealDealDocs.com.

With healthcare at the forefront of the coming elections, pharmaceutical companies, like Aronex Pharmaceuticals have found themselves in the spotlight. And when, in August of this year, Aronex Pharmaceuticals drafted their technology license agreement it was with a careful and conscious pen. That same week, Bayer Healthcare LLC entered a technology license agreement with Maxygen Holdings Limited adding to the curiosity of the American people. Both of these technology license agreements are available in their entirety on the RealDealDocs.com website.

A technology license agreement is a legal document granting permission to use, sell, distribute or assign a technology as set forth within the agreement.

RealDealDocs.com is the online legal document resource preferred by lawyers, deal professionals and entrepreneurs. The powerful search functionality is easy to use which is just one of the reasons 40 of the top 200 law firms in the world use it.  

The contracts, agreements and clauses available at RealDealDocs.com are the actual legal documents used by both the smallest of small capital companies as well as Fortune 500 companies alike. 

RealDealDocs.com helps to cut drafting time in half and provides unprecedented insight into the deal structures of the world’s largest companies. The legal documents may be searched for by category, law firm, parties involved or by the state of the governing law. Visitors can search the extensive RealDealDocs.com database absolutely free and members of the site may also download, copy, edit and print unlimited legal documents for their own personal or business use. Visit RealDealDocs.com for more information, membership options, and free legal document searches.

RealDealDocs.com is a division of Practice Technologies, Inc. the creators of SmartRules.com, the first online practice guide for the national litigator and the national litigation practice.

Want more publicity for this press release? Subscribe to the RSS feed!